Skip to main content
. 2019 Jul 24;18(3):3349–3357. doi: 10.3892/ol.2019.10655

Table V.

Association between lipid profile level in the different types of TC and lymph node metastasis among the participants.

PTC FTC MTC



Variable Metastasis Non-metastasis P-value Metastasis Non-metastasis P-value Metastasis Non-metastasis P-value
Age (years) 45.00 (38.0053.00) 50.00 (41.00–58.00) 0.050 49.50 (44.25–54.25) 51.00 (38.50–56.75) 0.909 47.50 (44.00–53.25) 48.00 (40.00–60.00) 0.869
CHO (mmol/l) 4.41 (3.80–5.07) 4.65 (4.07–5.31) 0.001 4.05 (1.08–4.69) 4.65 (3.91–5.47) 0.148 4.44 (3.93–5.43) 4.80 (4.18–5.26) 0.803
TG (mmol/l) 1.15 (0.79–1.80) 1.18 (0.78–1.78) 0.654 3.69 (1.24–4.78) 1.77 (1.08–2.34) 0074 1.45 (1.12–2.29) 1.40 (0.95–2.48) 0.914
HDL-C (mmol/l) 1.12 (0.96–1.30) 1.16 (1.00–1.37) 0.024 1.32 (0.98–1.52) 1.17 (0.95–1.38) 0.481 1.29 (1.02–1.73) 1.27 (1.04–1.51) 0.266
LDL-C (mmol/l) 2.50 (2.11–3.14) 2.69 (2.25–3.22) 0.003 2.47 (2.05–3.43) 2.86 (2.26–3.51) 0.392 2.66 (2.24–3.08) 2.83 (2.30–3.28) 0.521
Apo A1 (g/l) 1.32 (1.20–1.43) 1.35 (1.23–1.48) 0.023 1.22 (1.13–1.44) 1.35 (1.20–1.43) 0.493 1.52 (1.22–1.74) 1.36 (1.18–1.54) 0.114
Apo B(g/l) 0.85 (0.72–1.03) 0.91 (0.77–1.07) 0.006 0.9350 (0.7775–1.0825) 1.03 (0.77–1.15) 0.879 0.83 (0.78–1.04) 0.94 (0.80–1.07) 0.353
Lipoprotein (a) 75.00 85.00 0.043 89.50 124.00 0.581 35.00 71.00 0.105
(mg/l) (33.75–149.75) (42.00–177.00) (57.25–158.50) (47.75–379.25) (18.50–119.20) (29.75–192.00)
FFA (µmol/l) 466.00 487.00 0.416 462.00 374.00 0.502 586.00 478.00 0.862
(347.50–621.00) (344.00–638.50) (286.00–713.00) (309.00–584.00) (315.25–678.75) (351.50–673.50)
LDLC/HDL-C 2.28 (1.80–2.88) 2.33 (1.84–2.90) 0.542 2.04 (1.75–2.51) 2.77 (2.21–3.10) 0.057 2.37 (1.41–2.71) 2.26 (1.76–2.93) 0.317
ApoB/ApoA1 0.66 (0.64–0.80) 0.67 (0.56–0.81) 0.322 0.73 (0.60–0.94) 0.75 (0.65–0.86) 0.939 0.65 (0.43–0.79) 0.67 (0.52–0.86) 0.205

ApoA1, apolipoprotein A1; ApoB, apolipoprotein B; CHO, total cholesterol; FFa, free fatty acid; FTC, follicular thyroid carcinoma; HC, healthy controls; HDL-C, high-density lipoprotein-cholesterol; MTC, medullary thyroid cancer; PTC, papillary thyroid carcinoma; TG, triglyceride.